News
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...
Head-splitting migraines could be the next ailment in a seemingly endless list that a class of blockbuster weight-loss drugs ...
A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.
The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...
Participants with obesity (obesity cohort) were randomly assigned in a 3:3:3:2:2:2:3 ratio to receive maridebart cafraglutide subcutaneously at a dose of 140, 280, or 420 mg every 4 weeks without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback